Charles River Laboratories (CRL)
Solvency ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 2.28 | 2.30 | 2.39 | 2.48 | 2.55 | 2.81 | 2.84 | 2.71 | 2.77 | 2.91 | 2.90 | 2.66 | 2.60 | 2.75 | 2.99 | 3.15 | 2.87 | 2.99 | 3.18 | 2.81 |
The solvency ratios of Charles River Laboratories, as indicated by the debt-to-assets ratio, debt-to-capital ratio, and debt-to-equity ratio, have consistently been reported as 0.00 across all the periods provided. This suggests that the company operates with minimal debt relative to its assets, capital, and equity, reflecting a strong financial position and a low risk of insolvency due to debt obligations.
However, the financial leverage ratio, which measures the extent of a company's financial leverage or debt relative to its equity, has shown variability over the periods analyzed. The ratio has fluctuated between 2.28 and 3.18, with an upward trend observed from March 2021 to December 2022, suggesting an increase in financial leverage during this period. Subsequently, the ratio declined, indicating a decrease in financial leverage from December 2022 to September 2023.
Overall, while the debt-related solvency ratios show a stable and favorable position with minimal debt levels, the financial leverage ratio indicates some fluctuations in the company's leverage over time. Charles River Laboratories may benefit from monitoring and managing its financial leverage to maintain a balanced capital structure and optimize its solvency position.
Coverage ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 5.21 | 5.44 | 6.38 | 8.58 | 11.40 | 15.83 | 13.99 | 10.65 | 7.40 | 6.06 | 6.07 | 5.50 | 6.16 | 5.89 | 5.92 | 5.42 | 5.96 | 6.09 | 5.19 | 5.54 |
The interest coverage ratio for Charles River Laboratories has shown some fluctuations over the past few quarters. The ratio has generally been above 5, indicating the company's ability to cover its interest expenses with its operating income.
In the most recent quarter, the interest coverage ratio was 5.21, which decreased from the previous quarter's ratio of 5.44. However, when compared to the ratios from earlier quarters, such as the ratios in 2022 which ranged from 10.65 to 15.83, the recent ratios appear lower.
Overall, the trend in the interest coverage ratio for Charles River Laboratories shows that the company has had a relatively healthy ability to cover its interest expenses with its operating income. However, it would be important to keep an eye on future trends to ensure the company's financial health and stability.